Trial By Error: Another Nudge to Mahana ’ s Gasteroenterology Advisers
By David Tuller, DrPH Back in February, I wrote to some science advisers to Mahana Therapeutics to alert them to the company’s unjustified claims about the impact of its web-based program on the symptoms of irritable bowel syndrome. Two of them–Dr Peter Lu and Dr Carlo di Lorenzo–are gastroenterology specialists at Nationwide Children’s Hospital in […] (Source: virology blog)
Source: virology blog - April 28, 2020 Category: Virology Authors: David Tuller Tags: Uncategorized Source Type: blogs
Trial By Error: Revisiting Mahana and Irritable Bowel Syndrome …
By David Tuller, DrPH As the world continues to wrestle with the coronavirus epidemic, President Trump is calling on us here in the US to get back to work. So I decided to start seeking answers again from Mahana Therapeutics, which announced in January that it had licensed a web-based cognitive behavior therapy program for […] (Source: virology blog)
Source: virology blog - April 15, 2020 Category: Virology Authors: David Tuller Tags: David Tuller ME/CFS Source Type: blogs
Trial By Error: A Non-COVID Post about KCL ’ s Rejection of My FOI Request
By David Tuller, DrPH In the days before coronavirus was everything, I was writing about a major study of cognitive behavior therapy for irritable bowel syndrome. The study tested telephone-delivered cognitive behavior therapy, web-based CBT against treatment-as-usual for IBS symptom severity and other more generic domains. Although the pre-COVID era feels like ancient history already, […] (Source: virology blog)
Source: virology blog - April 8, 2020 Category: Virology Authors: David Tuller Tags: Uncategorized Source Type: blogs
Low-carb diets: Only the START to regain health and lose weight
While a low-carb diet is an excellent choice to achieve goals such as weight loss, stacking the odds in favor of reversing type 2 diabetes and fatty liver, and beginning the process of reversing skin rashes and autoimmune diseases, you don’t want to make the mistake of ending your efforts at diet alone.
Regardless of the variety of low-carb diet you choose—Atkins, paleo, keto, Wheat Belly, Undoctored, etc.—failure to add several components, especially prebiotic fibers that nourish bowel flora, can limit or even undo all of your health benefits. You can further your success by also addressing common nutri...
Source: Wheat Belly Blog - April 2, 2020 Category: Cardiology Authors: Dr. Davis Tags: Open grain-free microbiota prebiotic Weight Loss wheat belly Source Type: blogs
Trial By Error: Another Letter About Mahana; BerkeleyWellness on IBS Study
By David Tuller, DrPH I have been trying to find out why Mahana Therapeutics, a San Francisco-based start-up, has chosen to disseminate misleading information about a web-based cognitive behavior therapy program for people with irritable bowel syndrome. Because Mahana’s co-founder and CEO, Rob Paull, has not responded to my letters, I have contacted some of […] (Source: virology blog)
Source: virology blog - February 24, 2020 Category: Virology Authors: David Tuller Tags: David Tuller ME/CFS Source Type: blogs
Trial By Error: My Follow-up Letter to Mahana Therapeutics ’ CEO
By David Tuller, DrPH Last week, I wrote to Rob Paull, the co-founder and CEO of Mahana Therapeutics, regarding the company’s misleading claims about the web-based cognitive behavior therapy program for irritable bowel syndrome it recently licensed from King’s College London. I have also written to Professor Rona Moss-Morris, the co-lead investigator of ACTIB, the […] (Source: virology blog)
Source: virology blog - February 17, 2020 Category: Virology Authors: David Tuller Tags: David Tuller ME/CFS Source Type: blogs
Trial By Error: Some Thoughts on IBS, CFS, MUS, PACE, ACTIB and IAPT (Whew!)
By David Tuller, DrPH It might not be clear to many readers just why I’m spending time writing about irritable bowel syndrome when this series is supposed to be about the illness called myalgic encephalomyelitis (also referred to as chronic fatigue syndrome, ME/CFS, CFS/ME and other terms). The reason is that the two conditions have […] (Source: virology blog)
Source: virology blog - February 13, 2020 Category: Virology Authors: David Tuller Tags: Uncategorized Source Type: blogs
Trial By Error: My Follow-Up Letter to Professor Rona Moss-Morris
By David Tuller, DrPH Ten days ago, I sent a letter to Professor Rona Moss-Morris of King’s College London, seeking information about the licensing deal involving her web-based program of cognitive behavior therapy to treat irritable bowel syndrome. Since I have not heard back, this morning I made a second attempt to reach out to […] (Source: virology blog)
Source: virology blog - February 10, 2020 Category: Virology Authors: David Tuller Tags: David Tuller ME/CFS Source Type: blogs
Trial By Error: My Letter to Professor Moss-Morris
By David Tuller, DrPH Last week I wrote about the recently announced licensing deal between Mahana Therapeutics and King’s College London. The deal involves a web-based course of cognitive behavior therapy designed to treat irritable bowel syndrome. In a major study, the reported improvements in symptoms among participants in the web-based program were modest at […] (Source: virology blog)
Source: virology blog - February 3, 2020 Category: Virology Authors: David Tuller Tags: Uncategorized Source Type: blogs
Trial By Error: More on the Mahana Therapeutics Deal
By David Tuller, DrPH As I wrote yesterday, Mahana Therapeutics has recently licensed from King’s College London an “innovative digital therapeutic”—a web-based program delivering a course of cognitive behavioral therapy to patients with irritable bowel syndrome. A page on the Mahana site promoting this web-delivered IBS-CBT program furthers the impression that this deal is steeped […] (Source: virology blog)
Source: virology blog - January 28, 2020 Category: Virology Authors: David Tuller Tags: Uncategorized Source Type: blogs
